Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium

Human Molecular Genetics

Volumn 19, Issue 19, 2010, Pages 3873-3884

  Canzian, Federico ^a   Cox, David G ^b,c,d   Setiawan, V Wendy ^e   Stram, Daniel O ^e   Ziegler, Regina G ^f   Dossus, Laure ^a   Beckmann, Lars ^a   Blanché, Hélène ^g   Barricarte, Aurelio ^h   Berg, Christine D ^f   Bingham, Sheila ⁱ   Buring, Julie ^j   Buys, Saundra S ^k   Calle, Eugenia E ^l   Chanock, Stephen J ^f   Clavel Chapelon, Françoise ^m   DeLancey, John Oliver L ^l   Diver, W Ryan ^l   Dorronsoro, Miren ⁿ   Haiman, Christopher A ^e   Hallmans, Goran ^o   Hankinson, Susan E ^j   Hunter, David J ^b   Hüsing, Anika ^a   Isaacs, Claudine ^p   Khaw, Kay Tee ⁱ   Kolonel, Laurence N ^q   Kraft, Peter ^b   Le Marchand, Loïc ^q   Lund, Eiliv ^r   Overvad, Kim ^s   Panico, Salvatore ^t   Peeters, Petra H M ^u   Pollak, Michael ^v   Thun, Michael J ^l   Tjønneland, Anne ^w   Trichopoulos, Dimitrios ^b,x   Tumino, Rosario ^y   Yeager, Meredith ^f,z   Hoover, Robert N ^f   Riboli, Elio ^d   Thomas, Gilles ^f   Henderson, Brian E ^e   Kaaks, Rudolf ^a   Feigelson, Heather Spencer ^k,aa   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTRE LÉON BÉRARD   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g FONDATION JEAN DAUSSET CEPH   (France)

^h INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k UNIVERSITY OF UTAH   (United States)

^l AMERICAN CANCER SOCIETY   (United States)

^m INSTITUT GUSTAVE ROUSSY   (France)

ⁿ Department of Public Health of Guipuzcoa ^*  (Spain)

^o UMEÅ UNIVERSITY   (Sweden)

^p GEORGETOWN UNIVERSITY   (United States)

^q UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^r UNIVERSITY OF TROMSØ   (Norway)

^s AARHUS UNIVERSITY HOSPITAL   (Denmark)

^t UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^u UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^v MCGILL UNIVERSITY   (Canada)

^w INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^x BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^y CIVILE M P AREZZO HOSPITAL   (Italy)

^z SAIC FREDERICK INC   (United States)

^aa KAISER PERMANENTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID METABOLISM;

EID: 77956594771     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq291     Document Type: Article

References (84)

1. Bittner, J.J. (1947) The causes and control of mammary cancer in mice. Harvey Lect., 42, 221-246.
2. Henderson, B.E. (1988) Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 48, 246-253.
3. Pike, M.C., Spicer, D.V., Dahmoush, L. and Press, M.F. (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15, 17-35.
4. Key, T.J., Wang, D.Y., Brown, J.B., Hermon, C., Allen, D.S., Moore, J.W., Bulbrook, R.D., Fentiman, I.S. and Pike, M.C. (1996) A prospective study of urinary oestrogen excretion and breast cancer risk. Br. J. Cancer, 73, 1615-1619.
5. Hankinson, S.E. (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer. Inst., 90, 1292-1299.
6. Key, T., Appleby, P., Barnes, I. and Reeves, G. (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst., 94, 606-616.
7. Missmer, S.A., Eliassen, A.H., Barbieri, R.L. and Hankinson, S.E. (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J. Natl. Cancer Inst., 96, 1856-1865.
8. Kaaks, R., Berrino, F., Key, T., Rinaldi, S., Dossus, L., Biessy, C., Secreto, G., Amiano, P., Bingham, S., Boeing, H. et al. (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst., 97, 755-765.
9. Zeleniuch-Jacquotte, A., Gu, Y., Shore, R.E., Koenig, K.L., Arslan, A.A., Kato, I., Rinaldi, S., Kaaks, R. and Toniolo, P. (2005) Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study. Int. J. Cancer, 114, 323-327.
10. Hankinson, S.E. (2008) Circulating levels of sex steroids and prolactin in premenopausal women and risk of breast cancer. Adv. Exp. Med. Biol., 617, 161-169.
11. MacMahon, B. and Cole, P. (1969) Endocrinology and epidemiology of breast cancer. Cancer, 24, 1146-1151.
12. Clevenger, C.V., Furth, P.A., Hankinson, S.E. and Schuler, L.A. (2003) The role of prolactin in mammary carcinoma. Endocr. Rev., 24, 1-27.
13. Tworoger, S.S., Eliassen, A.H., Sluss, P. and Hankinson, S.E. (2007) A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J. Clin. Oncol., 25, 1482-1488.
14. Lee, S.A., Haiman, C.A., Burtt, N.P., Pooler, L.C., Cheng, I., Kolonel, L.N., Pike, M.C., Altshuler, D., Hirschhorn, J.N., Henderson, B.E. and Stram, D.O. (2007) A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. BMC Med. Genet., 8, 72.
15. Yager, J.D. and Davidson, N.E. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med., 354, 270-282.
16. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
17. Chlebowski, R.T., Kuller, L.H., Prentice, R.L., Stefanick, M.L., Manson, J.E., Gass, M., Aragaki, A.K., Ockene, J.K., Lane, D.S., Sarto, G.E. et al. (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N. Engl. J. Med., 360, 573-587.
18. Khandwala, H.M., McCutcheon, I.E., Flyvbjerg, A. and Friend, K.E. (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev., 21, 215-244.
19. Hadsell, D.L. and Bonnette, S.G. (2000) IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J. Mammary Gland Biol. Neoplasia, 5, 19-30.
20. Hursting, S.D., Lavigne, J.A., Berrigan, D., Donehower, L.A., Davis, B.J., Phang, J.M., Barrett, J.C. and Perkins, S.N. (2004) Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target. J. Nutr., 134, 2482S-2486S.
21. Yakar, S., Leroith, D. and Brodt, P. (2005) The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: lessons from animal models. Cytokine Growth Factor Rev., 16, 407-420.
22. Pollak, M. (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer, 8, 915-928.
23. Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Rosner, B., Speizer, F.E. and Pollak, M. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351, 1393-1396.
24. Kaaks, R., Lundin, E., Rinaldi, S., Manjer, J., Biessy, C., Söderberg, S., Lenner, P., Janzon, L., Riboli, E., Berglund, G. and Hallmans, G. (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control., 13, 307-316.
25. Renehan, A.G., Zwahlen, M., Minder, C., O'Dwyer, S.T., Shalet, S.M. and Egger, M. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-1353.
26. Schernhammer, E.S., Holly, J.M., Pollak, M.N. and Hankinson, S.E. (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 699-704.
27. Rinaldi, S., Peeters, P.H., Berrino, F., Dossus, L., Biessy, C., Olsen, A., Tjonneland, A., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M.C. et al. (2006) IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer, 13, 593-605.
28. Schernhammer, E.S., Holly, J.M., Hunter, D.J., Pollak, M.N. and Hankinson, S.E. (2006) Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr. Relat. Cancer, 13, 583-592.
29. Endogenous Hormones and Breast Cancer Collaborative Group (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol., 11, 530-542.
30. Hong, Y., Pedersen, N.L., Brismar, K., Hall, K. and de Faire, U. (1996) Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J. Clin. Endocrinol. Metab., 81, 1791-1797.
31. Harrela, M., Koistinen, H., Kaprio, J., Lehtovirta, M., Tuomilehto, J., Eriksson, J., Toivanen, L., Koskenvuo, M., Leinonen, P., Koistinen, R. et al. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. J. Clin. Invest., 98, 2612-2615.
32. Verhaeghe, J., Loos, R., Vlietinck, R., Herck, E.V., van Bree, R. and Schutter, A.M. (1996) C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: genetic versus environmental regulation. Am. J. Obstet. Gynecol., 175, 1180-1188.
33. Hall, K., Hilding, A. and Thoren, M. (1999) Determinants of circulating insulin-like growth factor-I. J. Endocrinol. Invest., 22, 48-57.
34. An, P., Rice, T., Gagnon, J., Hong, Y., Leon, A.S., Skinner, J.S., Wilmore, J.H., Bouchard, C. and Rao, D.C. (2001) Race differences in the pattern of familial aggregation for dehydroepiandrosterone sulfate and its responsiveness to training in the HERITAGE Family Study. Metabolism, 50, 916-920.
35. Meikle, A.W., Stringham, J.D., Woodward, M.G. and Bishop, D.T. (1988) Heritability of variation of plasma cortisol levels. Metabolism, 37, 514-517.
36. Rotter, J.I., Wong, F.L., Lifrak, E.T. and Parker, L.N. (1985) A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism, 34, 731-736.
37. Franks, S., Webber, L.J., Goh, M., Valentine, A., White, D.M., Conway, G.S., Wiltshire, S. and McCarthy, M.I. (2008) Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries. J. Clin. Endocrinol. Metab., 93, 3396-3402.
38. Dunning, A.M. (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 8, 843-854.
39. Coughlin, S.S. and Piper, M. (1999) Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 8, 1023-1032.
40. Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S. and Hirschhorn, J.N. (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet., 33, 177-182.
41. Pharoah, P.D., Tyrer, J., Dunning, A.M., Easton, D.F. and Ponder, B.A. (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet., 3, e42.
42. Dong, L.M., Potter, J.D., White, E., Ulrich, C.M., Cardon, L.R. and Peters, U. (2008) Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA, 299, 2423-2436.
43. Mavaddat, N., Dunning, A.M., Ponder, B.A., Easton, D.F. and Pharoah, P.D. (2009) Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Cancer Epidemiol. Biomarkers Prev., 18, 255-259.
44. Fletcher, O., Gibson, L., Johnson, N., Altmann, D.R., Holly, J.M., Ashworth, A., Peto, J. and dos Santos Silva, I. (2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol. Biomarkers Prev., 14, 2-19.
45. Canzian, F., McKay, J.D., Cleveland, R.J., Dossus, L., Biessy, C., Boillot, C., Rinaldi, S., Llewellyn, M., Chaje's, V., Clavel-Chapelon, F. et al. (2005) Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol. Biomarkers Prev., 14, 2316-2325.
46. Canzian, F., McKay, J.D., Cleveland, R.J., Dossus, L., Biessy, C., Rinaldi, S., Landi, S., Boillot, C., Monnier, S., Chaje's, V. et al. (2006) Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br. J. Cancer, 94, 299-307.
47. Cheng, I., Penney, K.L., Stram, D.O., Le Marchand, L., Giorgi, E., Haiman, C.A., Kolonel, L.N., Pike, M., Hirschhorn, J., Henderson, B.E. et al. (2006) Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer Epidemiol. Biomarkers Prev., 15, 1993-1997.
48. Wagner, K., Hemminki, K. and Försti, A. (2007) The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development. Breast Cancer Res. Treat., 104, 233-248.
49. Patel, A.V., Cheng, I., Canzian, F., LeMarchand, L., Thun, M.J., Berg, C.D., Buring, J., Calle, E.E., Chanock, S., Clavel-Chapelon, F. et al. (2008) Breast and Prostate Cancer Cohort Consortium. IGF-1, IGFBP-1 and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One, 3, e2578.
50. Hunter, D.J., Riboli, E., Haiman, C.A., Albanes, D., Altshuler, D., Chanock, S.J., Hayes, R.B., Henderson, B.E., Kaaks, R., Stram, D.O. et al. (2005) A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat. Rev. Cancer, 5, 977-985.
51. Risch, N. (2001) The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol. Biomarkers Prev., 10, 733-741.
52. Dunning, A.M., Healey, C.S., Baynes, C., Maia, A.T., Scollen, S., Vega, A., Rodríguez, R., Barbosa-Morais, N.L., Ponder, B.A., Low, Y.L. et al. (2009) Association of ESR1 gene tagging SNPs with breast cancer risk. Hum. Mol. Genet., 18, 1131-1139.
53. Cordell, H.J. and Clayton, D.G. (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet., 70, 124-141.
54. Haiman, C.A., Dossus, L., Setiawan, V.W., Stram, D.O., Dunning, A.M., Thomas, G., Thun, M.J., Albanes, D., Altshuler, D., Ardanaz, E. et al. (2007) Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res., 67, 1893-1897.
55. Dunning, A.M., Dowsett, M., Healey, C.S., Tee, L., Luben, R.N., Folkerd, E., Novik, K.L., Kelemen, L., Ogata, S., Pharoah, P.D. et al. (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J. Natl. Cancer Inst., 96, 936-945.
56. Johansson, M., McKay, J.D., Wiklund, F., Rinaldi, S., Verheus, M., van Gils, C.H., Hallmans, G., Bälter, K., Adami, H.O., Grönberg, H. et al. (2007) Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. J. Clin. Endocrinol. Metab., 92, 4820-4826.
57. Thompson, D.J., Healey, C.S., Baynes, C., Kalmyrzaev, B., Ahmed, S., Dowsett, M., Folkerd, E., Luben, R.N., Cox, D., Ballinger, D. et al. (2008) Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 17, 3490-3498.
58. Johansson, M., McKay, J.D., Wiklund, F., Rinaldi, S., Hallmans, G., Bälter, K., Adami, H.O., Grönberg, H., Stattin, P. and Kaaks, R. (2009) Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev., 18, 1644-1650.
59. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. and Rothman, N. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst., 96, 434-442.
60. Easton, D.F., Pooley, K.A., Dunning, A.M., Pharoah, P.D., Thompson, D., Ballinger, D.G., Struewing, J.P., Morrison, J., Field, H., Luben, R. et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1093.
61. Hunter, D.J., Kraft, P., Jacobs, K.B., Cox, D.G., Yeager, M., Hankinson, S.E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
62. Stacey, S.N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S.A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A. et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 39, 865-869.
63. Stacey, S.N., Manolescu, A., Sulem, P., Thorlacius, S., Gudjonsson, S.A., Jonsson, G.F., Jakobsdottir, M., Bergthorsson, J.T., Gudmundsson, J., Aben, K.K. et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 40, 703-706.
64. Thomas, G., Jacobs, K.B., Kraft, P., Yeager, M., Wacholder, S., Cox, D.G., Hankinson, S.E., Hutchinson, A., Wang, Z., Yu, K. et al. (2009) Amultistage genome-wide association study in breast cancer identifies two newrisk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet., 41, 579-584.
65. Zheng, W., Long, J., Gao, Y.T., Li, C., Zheng, Y., Xiang, Y.B., Wen, W., Levy, S., Deming, S.L., Haines, J.L. et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet., 41, 324-328.
66. Freedman, M.L., Haiman, C.A., Patterson, N., McDonald, G.J., Tandon, A., Waliszewska, A., Penney, K., Steen, R.G., Ardlie, K., John, E.M. et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl Acad. Sci. USA, 103, 14068-14073.
67. Gudmundsson, J., Sulem, P., Manolescu, A., Amundadottir, L.T., Gudbjartsson, D., Helgason, A., Rafnar, T., Bergthorsson, J.T., Agnarsson, B.A., Baker, A. et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet., 39, 631-637.
68. Haiman, C.A., Patterson, N., Freedman, M.L., Myers, S.R., Pike, M.C., Waliszewska, A., Neubauer, J., Tandon, A., Schirmer, C., McDonald, G.J. et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet., 39, 638-644.
69. Yeager, M., Orr, N., Hayes, R.B., Jacobs, K.B., Kraft, P., Wacholder, S., Minichiello, M.J., Fearnhead, P., Yu, K., Chatterjee, N. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.
70. Ghoussaini, M., Song, H., Koessler, T., Al Olama, A.A., Kote-Jarai, Z., Driver, K.E., Pooley, K.A., Ramus, S.J., Kjaer, S.K., Hogdall, E. et al. (2008) Multiple loci with different cancer specificities within the 8q24 gene desert. J. Natl Cancer Inst., 100, 962-966.
71. Calle, E.E., Rodriguez, C., Jacobs, E.J., Almon, M.L., Chao, A., McCullough, M.L., Feigelson, H.S. and Thun, M.J. (2002) The American Cancer Society Nutrition Cohort: rationale, study design and baseline characteristics. Cancer, 94, 2490-2501.
72. Riboli, E., Hunt, K.J., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondiere, U.R., Hemon, B., Casagrande, C., Vignat, J. et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr., 5, 1113-1124.
73. Colditz, G.A. and Hankinson, S.E. (2005) The Nurses' Health Study: lifestyle and health among women. Nat. Rev. Cancer, 5, 388-396.
74. Rexrode, K., Lee, I., Cook, N., Hennekens, C. and Buring, J. (2000) Baseline characteristics of participants in the Women's Health Study. J. Women's Health Gend. Based Med., 9, 19-27.
75. Hayes, R.B., Reding, D., Kopp, W., Subar, A.F., Bhat, N., Rothman, N., Caporaso, N., Ziegler, R.G., Johnson, C.C., Weissfeld, J.L. et al. (2000) Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control. Clin. Trials, 21, 349S-355S.
76. Kolonel, L., Henderson, B., Hankin, J., Nomura, A., Wilkens, L., Pike, M., Stram, D., Monroe, K., Earle, M. and Nagamine, F. (2000) A multiethnic cohort inHawaii andLosAngeles: baseline characteristics.Am. J.Epidemiol., 151, 346-357.
77. Stram, D.O., Haiman, C.A., Hirschhorn, J.N., Altshuler, D., Kolonel, L.N., Henderson, B.E. and Pike, M.C. (2003) Choosing haplotype-tagging SNPs based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum. Hered., 55, 27-36.
78. Goode, E.L., Fridley, B.L., Sun, Z., Atkinson, E.J., Nord, A.S., McDonnell, S.K., Jarvik, G.P., de Andrade, M. and Slager, S.L. (2007) Comparison of tagging single-nucleotide polymorphism methods in association analyses. BMC Proc., 1(Suppl. 1), S6.
79. Krawczak, M., Chuzhanova, N.A. and Cooper, D.N. (1999) Evolution of the proximal promoter region of the mammalian growth hormone gene. Gene, 237, 143-151.
80. Marchini, J. and Howie, B. (2008) Comparing algorithms for genotype imputation. Am. J. Hum. Genet., 83, 535-539.
81. de Bakker, P.I., Burtt, N.P., Graham, R.R., Guiducci, C., Yelensky, R., Drake, J.A., Bersaglieri, T., Penney, K.L., Butler, J., Young, S. et al. (2006) Transferability of tag SNPs in genetic association studies in multiple populations. Nat. Genet., 38, 1298-1303.
82. Sanna, S., Jackson, A.U., Nagaraja, R., Willer, C.J., Chen, W.M., Bonnycastle, L.L., Shen, H., Timpson, N., Lettre, G., Usala, G. et al. (2008) Common variants in the GDF5-UQCC region are associated with variation in human height. Nat. Genet., 40, 198-203.
83. Gao, X., Starmer, J. and Martin, E.R. (2008) A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet. Epidemiol., 32, 361-369.
84. Stram, D.O., Leigh Pearce, C., Bretsky, P., Freedman, M., Hirschhorn, J.N., Altshuler, D., Kolonel, L.N., Henderson, B.E. and Thomas, D.C. (2003) Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum. Hered, 55, 179-190.